AHCA gears up for lame duck fight, embraces 'quality' theme

Share this article:
Encouraging providers to focus on quality in their facilities continues to be the recurring theme at the American Health Care Association/National Center for Assisted Living convention, the head of the group told McKnight's on Tuesday. 

“What we've told our members is that quality has always been important to us,” AHCA/NCAL President and CEO Mark Parkinson told Editorial Director John O'Connor. “What's really changed is that quality has become a reimbursement issue…If we're going to be able to adapt to new payment models going forward, we're going to have to be able to hit these quality measures that we've put forward with our quality initiatives.”

While Parkinson was reluctant to predict a winner in the 2012 presidential race, he said he does expect to see nursing homes come under attack during the lame duck Congressional session. However, Parkinson said he thinks AHCA has been successful in lobbying against sequestration cuts.

“We've been effective in arguing that if sequestration can be delayed for defense, then it should be delayed for us. That's a very good thing for our members,” Parkinson said.

Click on the video above to watch the full interview.  Click here to see previous conference news.

The AHCA/NCAL conference concluded Wednesday in Tampa, FL.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.